Bob Burrows | Vice President, Investor Relations |
Bob Kramer | President & Chief Executive Officer |
Rich Lindahl | Chief Financial Officer |
Jessica Fye | JPMorgan |
Keay Nakae | Chardan |
Brandon Folkes | Cantor |
Good day and thank you for standing. Welcome to the Emergent BioSolutions Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.